These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 413843)

  • 21. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H; Naumann P; Reintjens E; Köhler M
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of in vitro and in vivo effect of gentamicin with other antibiotics (preliminary report).
    Výmola F; Jedlicková Z
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):244-5. PubMed ID: 4975927
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
    De Rosa F; Tassi C; Stagni GR
    Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K; Midtvedt T; Dahl O
    Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gentamicin resistance in Staphylococcus aureus--a new mechanism?
    Cutler RR
    J Antimicrob Chemother; 1983 Mar; 11(3):263-9. PubMed ID: 6841309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 29. Monitoring bacterial resistance to restricted antibiotics.
    Grunt J; Krcméry V; Rosival L
    Am J Hosp Pharm; 1978 Nov; 35(11):1387-9. PubMed ID: 101082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
    Knothe H; Kettner M; Kopsová D; Krcméry V
    Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.
    Bryan LE; Van Den Elzen HM
    Antimicrob Agents Chemother; 1977 Aug; 12(2):163-77. PubMed ID: 143238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides.
    Wilson SG; Sanders CC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):519-25. PubMed ID: 984794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of Pseudomonas aeruginosa in relation to laboratory-induced resistance to gentamicin.
    Dimitracopoulos G; Intzes C; Papavassiliou J
    J Clin Pathol; 1979 Jul; 32(7):723-7. PubMed ID: 115904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 39. Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification.
    Bryan LE; Haraphongse R; Van den Elzen HM
    J Antibiot (Tokyo); 1976 Jul; 29(7):743-53. PubMed ID: 821904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
    Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM
    J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.